pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Sep 18·1 min read
save

Geriatrician urges careful use of AI predictions for older patients

Sep 18, 2026·read at STAT ↗Neutral

Artificial intelligence tools are being added to electronic health records to flag patients at risk for conditions such as sepsis, falls or even death. The ease of integration has led many clinicians to accept the predictions without questioning how well the models work.

James Deardorff, a geriatrician and assistant professor at the University of California, San Francisco, has created several AI models that estimate outcomes for older adults, including mortality risk and the likelihood of needing nursing-home care. He emphasizes that the performance of these algorithms must be examined in detail, especially for sub-populations like the very elderly.

Deardorff warns that favorable predictions do not automatically translate into better patient outcomes. He calls for clinicians to understand the limitations of the models and to use the results responsibly, arguing that AI for older patients deserves careful scrutiny.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: A geriatrician explains why AI for older adults deserves careful scrutiny”

read at STAT ↗
574 words · retrieved Sep 18
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
University of California San Francisco
topics
Vaccines

related stories

  • Apr 30STAT+: Katherine Szarama named acting director of FDA’s vaccines and biologics centerSTAT
  • May 1STAT+: OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentenceSTAT
  • Apr 30Remembering J. Craig Venter: a relentless scientist who changed biotech — and was all too easily misunderstoodSTAT
  • Apr 30STAT+: In her own words: Surgeon general nominee Nicole Saphier expresses enthusiasm and caution for MAHASTAT
  • Apr 30Trump drops Casey Means as surgeon general nominee, opts for radiologist Nicole SaphierSTAT